CLPT Clearpoint Neuro Inc

P/E --
Forward P/E 12.11
Price/Sales 9.66
Beta 1.271
Div Yield --
Market Cap --

Company Analysis

Latest News

🟢 Clearpoint Neuro is trading 5% up today on healthcare-sector strength

Clearpoint Neuro is trading 5.1% up at $15.66, apparently supported by healthcare-sector strength rather than a company-specific catalyst. - No fresh...

🟢 Clearpoint Neuro is trading 7.58% up in pre-market despite no new company-specific catalyst

Clearpoint Neuro is trading 7.58% up at $16.03 after no new company-specific catalyst was identified for September 2, 2026. - The latest official...

🟢 Clearpoint Neuro is trading 10.75% up today — no clear company-specific catalyst identified

Clearpoint Neuro is trading 10.75% up at $16.80, with no clear company-specific catalyst identified for August 25, 2026. - The latest listed company release...

🟢 Clearpoint Neuro is trading 6% up today

Clearpoint Neuro is trading at $16.10, up 6.13%, with no clear catalyst identified. - No new company-specific announcement dated August 25, 2026 was...

Clearpoint Neuro's Revenue Miss and Guidance Cut Drain Cash and Confidence — Can a $500 Million Dream Survive a $29 Million Reality?

Clearpoint Neuro's Revenue Miss and Guidance Cut Drain Cash and Confidence — Can a $500 Million Dream Survive a $29 Million Reality?

Shares of Clearpoint Neuro sank 12.3% to $14.00 on August 20 as investors continued to punish the medical-device maker for second-quarter results that fell...

🔴 Clearpoint Neuro is trading 12.3% down in pre-market after Q2 earnings miss and revised 2026 guidance

Clearpoint Neuro is trading 12.3% down now at $14.00 after renewed attention to its second-quarter results and outlook. - Q2 revenue was $10.9 million, while...

🟢 Clearpoint Neuro rises 5.3% — Healthcare Stocks Surge on Strong Earnings Outlook and Investor Rotation

With Healthcare (XLV) up 3.2%, this looks like a sector-led move rather than a company-specific surprise. The healthcare sector experienced a significant...

🟢 Clearpoint Neuro is trading 6.4% up today on healthcare sector strength

Clearpoint Neuro is trading 6.4% up at $14.25 after recovering from the August 3 earnings-driven decline alongside broader healthcare strength. - The...

🟢 Clearpoint Neuro is trading 5.7% up in pre-market after August 3 earnings selloff

Clearpoint Neuro is trading 5.7% up at $14.15, reflecting broader healthcare strength and a rebound following its August 3 earnings selloff. - Healthcare...

Clearpoint Neuro's Cash Is Burning Fast — Can a $500 Million Dream Survive a 20% Stock Crash?

Clearpoint Neuro's Cash Is Burning Fast — Can a $500 Million Dream Survive a 20% Stock Crash?

Shares of Clearpoint Neuro cratered 20.2% to $12.28 after the brain-surgery device maker reported second-quarter results that exposed a widening gap between...

🔴 Clearpoint Neuro is trading 19% down today after cutting FY2026 guidance and posting a wider-than-expected loss

Clearpoint Neuro is trading 19% down at $12.41 after its August 3 earnings report revealed a wider-than-expected quarterly loss and a downward revision to...

🔴 Clearpoint Neuro is trading 15.5% down today after cutting full-year revenue guidance and reporting a wider net loss

Clearpoint Neuro is trading at $13.00 (15.5% down) after its second-quarter earnings disappointed and management lowered full-year 2026 revenue guidance. •...

🔴 Clearpoint Neuro is trading 20.2% down today after Q2 earnings miss, revenue miss, and guidance cut

Clearpoint Neuro is trading 20.2% down at $12.28 after reporting Q2 results that missed both revenue and earnings estimates and included a full-year 2026...

ClearPoint Neuro's second quarter revenue grew 18% to $10.9M, but the company lowered its full-year 2026 guidance.

ClearPoint Neuro's second quarter revenue grew 18% to $10.9M, but the company lowered its full-year 2026 guidance.

ClearPoint Neuro reported second quarter revenue of $10.9 million, an 18% increase year-over-year, which beat analyst estimates of $10.45 million. The company...

Clearpoint Neuro Inc Q2 2026 Earnings Preview: What Analysts Expect on August 03, 2026

Clearpoint Neuro is expected to report a Q2 loss of $0.29 per share on consensus revenue of $10.45 million, with the current stock price of $9.45 trading...

🔴 Clearpoint Neuro is trading 5.3% down today with no clear company-specific catalyst found

Clearpoint Neuro is trading at $14.14 (-5.33%) in after-hours trading with no clear company-specific catalyst found to explain the move from its regular...

🟢 Clearpoint Neuro is trading 5.9% up today amid broader market tailwinds

Clearpoint Neuro is trading 5.9% up at $14.95 in pre-market as broader market tailwinds and a strong risk-on tone lift equities. • The stock is rebounding...

🟢 Clearpoint Neuro is trading 5.6% up today in an isolated rebound after recent declines

Clearpoint Neuro is trading at $15.90 (5.6% up) as the stock stages an isolated rebound following a volatile week characterized by several consecutive...

🔴 Clearpoint Neuro is trading 5.2% down today amid risk-off sentiment in small-cap healthcare

Clearpoint Neuro is trading at $16.59 (5.2% down) today as the stock faces pressure from broader market weakness and a shift away from high-growth, loss-making...

🔴 Clearpoint Neuro is trading 5.6% down today amid broader market weakness and soft tech sentiment

Clearpoint Neuro is trading at $16.88 (-5.58%) in pre-market sessions as broader market weakness and uneven technology sentiment weigh on small-cap healthcare...